ArticlePreventive medicine reports2025
Prevalence of clinician-ordered genetic testing in rural and urban United States counties: An analysis of the 2022 Health Information National Trends Survey.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Precision Medicine in Rural Settings: Clinician Perspectives on Clinician-Ordered Genetic Testing.Research square · 2026Article
- Precision Medicine in Rural Settings: Patient Perspectives on Clinician-Ordered Genetic Testing.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Rural residents face challenges to realizing guideline-concordant healthcare. Less is known about the role of rurality in achieving guideline-concordant genetic testing. To address this gap, we estimated the association between rural residence and two types of clinician-ordered genetic testing among individuals who had heard of genetic testing. Methods: In 2024, we considered the 4559 individuals (80.0 % of respondents) who indicated that they had heard of genetic testing in the cross-sectional Health Information National Trends Survey wave 6, collected in the United States, March 7 - November 8, 2022, to assess the association between rurality and two types of clinician-ordered genetic testing, reproductive carrier and disease risk testing. Log binomial regression models estimated the prevalence ratios of two types of guideline-concordant clinician-ordered genetic testing while adjusting for sociodemographic characteristics. Results: Of the 4559 respondents assessed for eligibility, 976 and 3933 responses were eligible for analysis of clinician-ordered reproductive genetic carrier testing and disease risk testing, respectively. The prevalence of clinician-ordered reproductive carrier and disease risk genetic testing did not vary by rurality in adjusted multivariable regression analyses (adjusted prevalence ratio (aPR): 0.71, 95 % CI 0.38-1.33, aPR: 1.23, 95 % CI 0.86-1.75, respectively). Conclusions: Clinician-ordered genetic testing does not appear to be associated with geography among individuals who have heard of genetic testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.